Immunohistochemical FMRP Studies in a Full Mutated Female Fetus

American Journal of Medical Genetics

Volumn 124 A, Issue 2, 2004, Pages 129-132

  Rife M ^a,c   Nadal, A ^b   Milà, Montserrat ^a,c   Willemsen, R ^d  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Females fetus; FMRP; Fragile X syndrome; Full mutation

Indexed keywords

BRAIN PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN;

ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL COUNT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FETUS; FETUS DEVELOPMENT; GENE MUTATION; GERM CELL; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUELLERIAN DUCT; MUTATIONAL ANALYSIS; OVARY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; UTERINE TUBE MUCOSA; X CHROMOSOME INACTIVATION;

FALLOPIA;

EID: 0347417909     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.20342     Document Type: Article

References (29)

1. Agulhon C, Blanchet P, Kobetz A, Marchant D, Faucon N, Sarda P, Moraine C, Sittler A, Biancalana V, Malafosse A, Abitbol M. 1999. Expression of FMR1, FXR1, and FXR2 genes in human prenatal tissues. J Neuropathol Exp Neurol 58:867-880.
2. Antinolo G, Borrego S, Cabeza JC, Sanchez R, Sanchez J, Sanchez B. 1996. Reverse mutation in fragile X syndrome. Hum Genet 58:237-239.
3. Bakker CE, de Diego Otero Y, Bontekoe C, Raghoe P, Luteijn T, Hoogeveen AT, Oostra BA, Willemsen R. 2000. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res 258:162-170.
4. de Vries BB, Wiegers AM, Smits AP, Mohkamsing S, Duivenvoorden HJ, Fryns JP, Curfs LM, Halley DJ, Oostra BA, van den Ouweland AM, Niermeijer MF. 1996. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 58:1025-1032.
5. Devys D, Biancalana V, Rousseau F, Boue J, Mandel JL, Oberlé I. 1992. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet 43:208-216.
6. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. 1993. The FMR1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
7. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick Jr, Warren ST. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67:1047-1058.
8. Hagerman RJ. 1996. Physical and behavioral phenotype. In: Hagerman RJ, Silverman AC, editors. Fragile X syndrome: Diagnosis, treatment, and research. Baltimore and London: The John Hopkins University Press. p 3-87.
9. Khandjian EW, Bardoni B, Corbin F, Sittler A, Giroux S, Heitz D, Tremblay S, Pinset C, Montarras D, Rousseau F, Mandel J. 1998. Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis. Hum Mol Genet 7:2121-2128.
10. Kruyer H, Mila M, Glover G, Carbonell P, Ballesta F, Estivill X. 1994. Fragile X syndrome and the (CGG)n mutation: Two families with discordant MZ twins. Am J Hum Genet 54:437-442.
11. Lyon MF. 2002. X-chromosome inactivation and human genetic disease. Acta Paediatr Suppl 91:107-112.
12. Milà M, Kruyer H, Glover G, Sànchez A, Carbonell P, Castellvi-Bel S, Volpini V, Rosell J, Gabarrón J, López I, Villa M, Ballesta F, Estivill X. 1994. Molecular analysis of the (CGG)n expansion in the FMR1 gene in 59 Spanish fragile X syndrome families. Hum Genet 94:395-400.
13. Oberlé I, Rousseau F, Heitz D, Kretz C, Debys D, Hanauer A, Boué J, Bertheas M, Mandel JL. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
14. Oostra BA, Willemsen R. 2001. Diagnostic tests for fragile X syndrome. Expert Rev Mol Diagn 1:226-232 (Review).
15. Pieretti M, Zhang F, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. 1991. Absence of expression of the FMR1 gene in fragile X syndrome. Cell 66:817-822.
16. Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian development. Science 293:1089-1093 (Review).
17. Riddle JE, Cheema A, Sobesky WE, Gardner SC, Taylor AK, Pennington BF, Hagerman RJ. 1998. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard 102:590-601.
18. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacobs PA, Schwartz C, Mandel JL. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe STB12.3: The first 2,253 cases. Am J Hum Genet 55:225-237.
19. Sobesky WE, Taylor AK, Pennington BF, Bennetto L, Porter D, Riddle J, Hagerman RJ. 1996. Molecular/clinical correlations in females with fragile X. Am J Med Genet 64:340-345.
20. Tamanini F, Willemsen R, van Unen L, Bontekoe C, Galjaard H, Oostra B, Hoogeveen AT. 1997. Differential expression of FMR1, FXR1, and FXR2 proteins in human brain and testis. Hum Mol Genet 6:1315-1322.
21. Tassone F, Hagerman RJ, Iklé DN, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK. 1999. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 84:250-261.
22. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, Staley LW, Hagerman RJ. 1994. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 271:507-514.
23. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuhl PA, Pizutti A, Reiner O, Richards S, Victoria Mf, Zhang F, Eussen BE, Van Ommen GJB, Blonden LAJ, Riggins GJ, Chastain JL, Kunts CB, Galjaard H, Caskey CT, Nelson D, Oostra BA, Warren ST. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
24. Vink GR, Froster UG. 2002. Comparision of FMR1-protein expression in lymphocytes, methylation pattern in Southern blot analysis, and IQ values in three sisters with the Fragile X Syndrome. Am J Med Genet 107:344-345.
25. Willemsen R, Oostra BA. 2000. FMRP detection assay for the diagnosis of the Fragile X syndrome. Am J Med Genet (Semin Med Genet) 97:183-188.
26. Willemsen R, Smits A, Mohkamsing S, van Beerendonk H, de Haan A, de Vries B, van den Ouweland A, Sistermans E, Galjaard H, Oostra BA. 1997. Rapid antibody test for diagnosing fragile X syndrome: A validation of the technique. Hum Genet 99:308.311.
27. Willemsen R, Olmer R, De Diego Y, Oostra BA. 2000. Twin sisters, monozygotic with the fragile X mutation, but with a different phenotype. J Med Genet 37:603-604.
28. Willemsen R, Bontekoe CJM, Severijnen LA, Oostra BA. 2002. Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum Genet 110:601-605.
29. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, Holman K, Mulley JC, Warren ST, Schelessinger D, Sutherland GR, Richards IR. 1991. Fragile X genotype characterized by an unstable region of DNA. Science 252:1179-1181.